Caption Management’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$7.04M Buy
+90,000
New +$7.26M 0.03% 496
2025
Q4
Sell
-11,700
Closed -$1.14M 1884
2025
Q3
$1.11M Sell
11,700
-31,300
-73% -$2.88M 0.01% 1063
2025
Q2
$3.75M Buy
+43,000
New +$3.65M 0.04% 493
2024
Q1
Sell
-40,000
Closed -$3.3M 1490
2023
Q4
$3.3M Buy
+40,000
New +$3.05M 0.04% 474
2022
Q3
Sell
-25,875
Closed -$2.33M 1712
2022
Q2
$2.32M Buy
25,875
+7,230
+39% +$733K 0.03% 620
2022
Q1
$2.07M Sell
18,645
-150,785
-89% -$15.9M 0.02% 741
2021
Q4
$17.5M Buy
169,430
+94,430
+126% +$10.9M 0.2% 120
2021
Q3
$9.4M Buy
+75,000
New +$9.71M 0.11% 246
2020
Q1
Sell
-27,500
Closed -$3.12M 984
2019
Q4
$3.12M Sell
27,500
-2,500
-8% -$274K 0.1% 267
2019
Q3
$3.26M Buy
+30,000
New +$3.13M 0.17% 164

Other funds holding MDT

Caption Management's MDT Position: Q2 2026 in Review

Caption Management opened a new position in Medtronic (MDT) in Q2 2026: 90,000 shares worth $7.04M. The stake represents 0.03% of the portfolio and ranks #496 among its holdings. This is a return to the name: Caption Management previously reported a position in MDT as recently as Q3 2025.

Caption Management first reported a position in MDT in Q3 2019 and has held it in 10 quarters since. The position peaked at $17.5M in Q4 2021. 2,128 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

  • Caption Management held 90,000 shares of Medtronic worth $7.04M as of Q2 2026.
  • Medtronic was a new Caption Management position in Q2 2026.
  • Medtronic made up 0.03% of Caption Management's portfolio in Q2 2026, its #496 holding.
  • Caption Management first reported a position in Medtronic in Q3 2019 and has held it in 10 quarters since.
  • Caption Management's Medtronic position peaked at $17.5M in Q4 2021.
  • 2,128 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on Caption Management's 13F filing for Q2 2026, filed 14 Aug 2026.